# 1% Lidocaine Paracervical Block for Endometrial Biopsy

> **NCT06546254** · NA · COMPLETED · sponsor: **Mount Sinai Hospital, Canada** · enrollment: 96 (actual)

## Conditions studied

- Endometrial Biopsy

## Interventions

- **DRUG:** Lidocaine 1% Injectable Solution
- **OTHER:** Capped needle

## Key facts

- **NCT ID:** NCT06546254
- **Lead sponsor:** Mount Sinai Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-19
- **Primary completion:** 2026-01-22
- **Final completion:** 2026-01-22
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546254, "1% Lidocaine Paracervical Block for Endometrial Biopsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06546254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*